EIGHTH ANNUAL WORLD COURSE IN 

BRAIN TUMOUR SURGERY

 

LONDON, JULY 18-21, 2019

FACULTY

MEET THE MASTERS.

ALL UNDER ONE ROOF!

GEORGE SAMANDOURAS​

Consultant Neurosurgeon

The National Hospital for Neurology and Neurosurgery

University College London

Queen Square, London

George Samandouras trained in Neurosurgery in Oxford receiving numerous teaching awards from the University of Oxford before becoming Consultant Neurosurgeon in November 2009 at the National Hospital for Neurology and Neurosurgery, the world's first institution specializing in brain pathologies. He runs a neuro-oncology service with high volume awake craniotomies and resection of gliomas in eloquent parts of the brain. He is invited annually to present his work to the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS) and other international societies. He is an invited member of the Executive Committee of the AANS/CNS joint section on tumours (2016-2020). His bestselling book "The Neurosurgeon's Handbook", Oxford University Press, has been translated to Chinese in 2015.

 

 

Mr Samandouras is directing the Course along with Dr Berger, and together they have invited some of the most eminent surgeons, clinicians and scientists at the forefront of brain tumour treatments. Mr Samandouras will be coordinating all live surgeries from London, and he will present the surgical anatomy of eloquent white matter tracts in the "Surgical Anatomy" section on Saturday morning and next day he will describe his brain mapping and surgical techniques.

MITCHEL BERGER​

Professor and Chairman, Department of Neurosurgery

University of California, San Fransisco, USA

Professor Berger is the Director of the Brain Tumor Surgery Program and Director of the Neurosurgical Research Centers. His main clinical interests are the treatment of brain tumours in adults and children. He has extensive expertise in the intraoperative mapping of the brain to identify the sites of the motor, sensory, and language function and thereby avoid their involvement or injury during surgery. His current research interests involve identifying molecular markers in gliomas as correlates of tumour progression and prognosis. Dr Berger is currently the Principal Investigator of UCSF's SPORE Brain Tumor Program, funded by the National Cancer Institute and NINDS. His articles, books and lectures have changed the practice of neurooncology worldwide.

 

 

Dr Berger, Course Co-Director, will be performing an awake craniotomy with mapping in his OR at UCSF, showing in detail his unique mapping and surgical techniques, and demonstrate what he has learned and passed on to a generation of neurosurgeons. The audience will have the privilege to watch live with multiple viewing angles some of these techniques and will have the opportunity to ask Dr Berger in person, in London, questions.

MICHAEL LAWTON

President & CEO, Barrow Neurological Institute, Chairman, Department of Neurological Surgery, Barrow Brain and Spine, Phoenix, AZ, USA

Dr Lawton’s neurosurgical expertise includes cerebrovascular disorders (aneurysms, arteriovenous malformations, cavernous malformations, and stroke) and skull base tumours. He has experience in treating more than 4,000 brain aneurysms, 800 AVMs, and 1,000 cavernous malformations. He is the principal investigator for the Brain Vascular Malformation Consortium, an NIH-funded multicenter group studying the genetics and clinical course of rare vascular diseases of the brain. He has published over 450 peer-reviewed articles, three single-author textbooks, and over 70 book chapters. He co-founded Mission: BRAIN, a teaching mission to raise the level of neurosurgery practised in developing countries that conducts annual missions in Mexico and Asia.

 

Dr Lawton, the new CEO of Barrow Neurological Institute, and one of the most skilled and experienced vascular neurosurgeons in the world was invited in the Faculty due to his experience in mapping AVMs in eloquent parts of the brain. Also, his techniques in splitting the Sylvian fissure and handling vessels will be of tremendous benefit to tumour surgeons. He will be performing live surgery from Barrow, and he will be teaching in London the surgical anatomy of the Sylvian fissure in the "Surgical Anatomy" section and he will be also describing his vascular surgery experience in the Master's Seminar. 

HUGUES DUFFAU

Professor and Chairman, Department of Neurosurgery

University of Montpellier, France

Professor Duffau is Chairman of the Neurosurgery Department of the Montpellier University Medical Center and Head of the INSERM 1051 Team "Plasticity of the central nervous system, human stem cells and glial tumours" at the Institute for Neurosciences of Montpellier. He is an expert in the awake cognitive neurosurgery of slow-growing brain tumours, (low-grade gliomas), a routine which he has developed over twenty years. For his innovative work in neurosurgery and neurosciences, he was awarded Doctor Honoris Causa several times, and he was the youngest recipient of the prestigious Herbert Olivecrona Award from the Karolinska Institute in Stockholm. He has written four textbooks and over 300 publications in international journals ranging from neurosurgery to fundamental neurosciences.

 

 

Dr Duffau holds some of the largest series of low-grade glioma surgery internationally and is credited for introducing the concept of plasticity in glioma surgery and also for introducing cognitive neuroscience methods in neurosurgery. With hundreds of publications, many in neuroscience journals, has pioneered many original neurooncology concepts. He will be discussing his experience in London, and as an extra bonus for the delegates, he will be performing a piano recital during the Saturday night Gala dinner.

THEODORE SCHWARTZ 

 

David and Ursel Barnes Professor of Minimally Invasive Neurosurgery 

Department of Neurosurgery, Otolaryngology and Neuroscience, Director, Anterior Skull Base and Pituitary Surgery, Director, Epilepsy Research Laboratory, Will Cornell Medicine, New York, USA

Dr Schwartz is among the nation’s leading neurological surgeons specializing in brain tumour and epilepsy surgery. He has been named to the lists of New York’s Super Doctors, Best Doctors in New York magazine, America’s Top Surgeons, America’s Best Doctors, and America’s Best Doctors for Cancer. His research has been widely published and he has received numerous national awards. He is particularly known for advancing the use of state-of-the-art intraoperative technology, such as minimally invasive endoscopy, brain mapping, and intraoperative imaging.

 

 

Dr Schwartz, one of the most experienced and skilled endoscopic pituitary surgeons, will perform an endoscopic pituitary surgery in his OR in New York along with his ENT colleagues,  and when he will arrive in London, he will present the endoscopic sellar anatomy in the "Surgical Anatomy" section on Saturday morning and later that afternoon will describe his surgical techniques in his Master's Seminar.

HELMUT BERTALANFFY

Professor of Neurosurgery and Director of Vascular Neurosurgery

International Neuroscience Institute, Hannover, Germany

Dr. Bertalanffy was appointed as Professor by the State of Hessen, Germany, in 1997 and served as Professor and Chairman of the Depart­ment of Neurosurgery of the Philipps University of Marburg for 10 years. In July 2007 he was appointed as Chairman of the Department of Neurosurgery of the University of Zurich, Switzerland, Yasargil's previous position, where he served three and a half years. In November 2010 he accepted the new position of Director of the Center for Vascular Neurosurgery at the prestigious International Neuroscience Institute (INI) in Hannover, Germany. He is the Editor-in-Chief of the journal Neurosurgical Review. He has published over 150 articles in peer-reviewed journals and contributed over 50 book chapters or other articles to medical texts.

 

 

Dr Bertalanffy, an extremely skilled and meticulous skull base, vascular and tumour surgeon, will be performing surgery on a skull base meningioma from the renowned International Neuroscience Institute in Hannover and he will then be discussing in London, the surgical anatomy of the brainstem and posterior cranial fossa in the "Surgical Anatomy" section and his meticulous techniques in the "Master's Seminar. 

GEORGE JALLO

Professor of Neurosurgery and Director of Pediatric Neurosurgery

Johns Hopkins All Children's Hospital, USA

Dr Jallo, is an internationally respected pediatric neurosurgeon, with his fellowship training in pediatric neurosurgery under Dr Fred Epstein. He joined the newly established Johns Hopkins All Children’s Institute for Brain Protection Sciences.  after more than a decade at Johns Hopkins University in Baltimore, where he is a professor of neurosurgery, paediatrics and oncology and succeeded Benjamin Carson, M.D., as head of the division of pediatric neurosurgery. Dr Jallo's clinical interests involve new treatment modalities for diffuse pontine gliomas in children. He is currently investigating the results of current medical therapies and protocols.

 

 

Dr Jallo is a recognised authority on brainstem and spinal cord tumour surgery. He will be performing a paediatric intrinsic spinal cord tumour with neurophysiological monitoring in his own OR and subsequently, in London he will be teaching the surgical anatomy of the spinal cord as well as his techniques in the brainstem and spinal cord surgery. 

LORENZO BELLO

 

Professor of Neurosurgery

Università degli Studi di Milano

Head of NeuroSurgical Oncology Unit,

Humanitas Neuro and Cancer, Center, Humanitas Research Hospital, Milano, Italy

Professor Bello leads a group of neurosurgeons, neurophysiologists, neuropsychologists dedicated in the treatment of brain tumours. An average of 500 cases of brain tumours are surgically treated each year (250 low grade), and an overall number of more than 2000 cases are treated by the group each year. His research is on brain mapping techniques, image-guided surgery, and translational research on angiogenesis and invasion. He is leading one the more active group in Europe on low-grade gliomas research. Most recent work is focused on the functional organization of the corticospinal tract, and on the connection between frontal and parietal areas. He is Co-director of the ELAT, an INSERM associated laboratory, studying mechanisms of angiogenesis and invasion in cancer.

 

 

Dr Bello has a unique understanding and insight into the anatomical and physiological organisation of the motor system. His knowledge as a surgical neurophysiologist, allows him to operate in tumours in or around the primary motor cortex and corticospinal tracts with surgical outcomes. He will demonstrate during live surgery, from Milan, Italy, his techniques and later in London with will describe the advanced surgical anatomy of the motor pathway applied to glioma surgery. 

JINSONG WU

Professor, Glioma Surgery Division, Neurosurgery Department of Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China

Dr Wu has been established as an academic leader in Chinese neurosurgery with numerous high-quality contributions to glioma surgery in eloquent parts of the brain. He developed his own novel integrated technical system for multimodal brain mapping strategies and established a Chinese language cortical distribution atlas. He has been a principal investigator of numerous projects and has been awarded distinctions by the Congress of Neurological Surgeons, The Journal of Neuro-oncology, the Shanghai government and the Chinese Neurosurgical Association. He will be demonstrating awake craniotomy techniques, with technologies he devised himself, on a 3T iMRI.

 

 

Dr Wu specialises in glioma surgery, performing an increasingly larger number of glioma surgery, including awake craniotomies in intraoperative MRI; it likely that soon Dr Wu will have the larger number of awake craniotomies internationally. Following an awake craniotomy on intraoperative MRI in Shanghai, will come to London where he will describe his experience in running a very specialised service. 

ATUL GOEL

Professor and Chairman

Department of Neurosurgery of Neurosurgery

KEM Hospital, Mumbai,  India

Dr Atul Goel's medical interest include skull base surgery, pituitary tumour surgery, and spinal surgery. He is Chief Neurosurgeon at TATA Memorial Hospital and Cancer Research Institute in Parel, Mumbai, India. Apart from holding the position of Editor at the Journal of Postgraduate Medicine and Neurology India, he has also served on the Editorial Boards of multiple medical journals and has co-authored the book Neurosurgery of Complex Tumors and Vascular Lesions. He has published many peer-reviewed articles.

 

 

 

Dr Goel a surgeon with extensive experience in complex skull base lesions will perform a craniotomy for a cavernous sinus lesion, one of the most challenging operations in neurosurgery, in his OR in Mumbai; in London, he will describe his techniques and take part in roundtables with the rest of the Faculty

GUILHERME RIBAS

 

Professor of Surgery

University of Sao Paulo Medical School

Albert Einstein Hospital

Brazil

Professor Ribas runs a research laboratory at the Hospital Beneficência Portuguesa, focusing on microneurosurgical anatomy and on cranial neurosurgical techniques; he has published more than 50 articles and 40 book chapters. He is a pioneer of stereoscopic publications in neurosurgical journals (Journal of Neurosurgery, December 2001, with its cover illustration), and his lectures are mostly done with 3D techniques since 1995. In 2010 his article The Cerebral Sulci and Gyri was the most accessed article of the whole Journal of Neurosurgery Publishing Group. He is a member of the editorial staff of the Neurosurgical Focus,  Journal of Neurosurgery Video Supplement and reviewer for Neurosurgery,  and World Neurosurgery.

 

 

 

Dr Ribas is a neurosurgeon and one of the rare anatomical teachers where it is obvious, from the first few minutes of listening to him, that teaching the structure of the brain is a lifelong passion. His unique understanding of the gyral and sulcal anatomy as well as safe entry points into deep-seated lesions.  

MICHAEL WELLER

Chairman of the Department of Neurology,  University Hospital Zurich, Switzerland

Chairman EORTC

Dr Weller has received several awards in recognition of his contributions to cancer research, including the German Cancer Award in 2007. He served as Chairman of the Neuro-Oncology Group of the German Cancer Society from 2001-2008. He is the Chairman of the German Glioma Network of the German Cancer Council. He hosted the World Federation of Neuro-Oncology Societies (WFNOS) Meeting in May 2017 in Zurich, Switzerland, and is the He serves as the CNS Tumours Track Chair for the ESMO 2017 Congress in Madrid.Dr. Weller has co-authored more than 600 original publications in peer-reviewed journals, including The New England Journal of Medicine, Science, Nature, Nature Medicine, Lancet Oncology, PNAS, The Journal of Clinical Investigation, and The Journal of Clinical Oncology.

 

 

Dr Weller is the current Chairman of the European Organisation for Research and Treatment of Cancer (EORTC, 2015-2021) a network of more than 5,500 scientists in 27 countries, and one of the most authoritative opinions in current neuro-oncology. Dr Weller, he will be discussing his current views in the future of neurooncology and he will take part in a roundtable on conducting research and publishing articles in neuro-oncology.

SUSAN CHANG

 

Director, Neuro-Oncology Division & Leader, Neuro-Oncology Program, Helen Diller Comprehensive Cancer Center, Univerisity of California, San Francisco, USA 

 

Dr. Chang performs clinical trials about brain tumor therapy protocols and experimental therapeutic regimens for adult patients. In addition to research into developing novel and effective therapeutic strategies for the treatment of patients with primary brain tumours, her research goals include the evaluation of novel imaging techniques that may influence treatment selection for patients. She is the Neuro-Oncology Program Leader of the UCSF comprehensive cancer centre and is co-PI of a program project grant evaluating imaging and tissue biomarkers of glioblastoma. She has recently been co-recipient of a SPORE project for evaluating the role of magnetic resonance spectroscopy in diagnosing tumours and evaluating therapeutic interventions.  She is also the chair of the Developmental Study Section at the NIH. 

 

Dr Chang, an internationally respected neuro-oncologist, and serves in leadership roles in the Society of Neuro-Oncology and is the editor in chief of Neuro-Oncology Practice- a journal that focuses on the clinical aspects of the management of patients with an emphasis on quality of life and neurocognitive function.  Dr Chang is the director of the UCSF Neuro-Oncology Gordon Murray Caregiver Program and co-director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program.  These programs complement the clinical care of patients and add an additional level of support to enhance the quality of life of patients and caregivers.  

STEVEN KALKANIS

 

Professor & Chairman, Department of Neurosurgery

Henry Ford Hospital, Detroit, MI, USA

President-elect, Congress of Neurological Surgeons  

Director, American Board of Neurological Surgery

Past Chair, AANS/CNS Section on Tumors

Dr. Kalkanis is also co-Director of the Neuroscience Institute at Henry Ford Health System in Detroit, Michigan, where he also serves as Director of the Henry Ford Cancer Institute. Dr. Kalkanis completed his neurosurgical training at Massachusetts General Hospital. He graduated with highest honors from Harvard University, where he was awarded the John Harvard Scholarship, and then Harvard Medical School, where he served as class marshal and received the Linnane Prize for highest academic achievement. He is involved in numerous trials, task forces and guidelines committees for the evidence-based management of brain tumours. he has a special interest in precision medicine.  

 

 

 

Dr Kalkanis, President-Elect of the Congress of Neurological Surgeons, will discuss the latest advances on precision medicine and applications to the management of brain tumours. Also, with his leadership positions, he will provide a description of the current trends and an estimate of the future trends in surgical neuro-oncology.

ROGER STUPP

 

Chief of Neuro-Oncology

Feinberg School of Medicine

Northwestern Medicine

Chicago, IL, USA

Dr Stupp has been the lead investigator for establishing the use of temozolomide chemotherapy in conjunction with radiotherapy in patients with newly diagnosed glioblastoma and determining the predictive value of MGMT gene-promoter methylation. He co-chairs several randomized clinical trials, including EORTC 22033-26033, comparing primary chemotherapy versus radiotherapy in patients with low-grade glioma, and trials on novel agents or modalities in patients with recurrent glioma. Dr Stupp maintains close collaborations with the Laboratory of Tumor Biology and Genetics at CHUV, the Laboratory of Tumor Angiogenesis and Melanoma Research, and the Swiss Institute of Experimental Cancer Research (ISREC).

 

 

Dr Stupp, an internationally recognised authority in the treatment of brain tumours, and Faculty of the London Course since its first year in 2012, and for every consecutive year since, will bring a lot of interactions and discussions with the Delegates and he will discuss how to critically read and assess the neuro-oncology literature, including articles published in high-impact journals; this will be an unprecedented opportunity to delegates on dissecting current evidence and improving future efforts. 

ERIK SULMAN

 

Professor of Radiation Oncology

Co-Director, Brain Tumor Center

New York University, USA

 

Dr Sulman joined recently the NYU Langone from The University of Texas MD Anderson Cancer Center, where he was a tenured associate professor of radiation oncology, translational molecular pathology, and genomic medicine, and section chief of the central nervous system and pediatric radiation oncology. Dr Sulman is a nationally recognized figure in brain tumour research, selected to multiple prestigious committees, including his recent election to the Board of the Society for Neuro-Oncology. He has authored more than 100 manuscripts, including publications in top-tier peer-reviewed journals, such as Nature, Cancer Cell, Neuro-Oncology, and Clinical Cancer Research.

 

 

Dr Sulman who received the American Society for Radiation Oncology Translational Research in Radiation Oncology amongst many other awards serves as principal investigator on R01 grants and Specialized Programs of Research Excellence projects funded by the NIH and directs integral biomarker evaluation on some of the largest, NIH-funded clinical trials for brain tumour patients. He will be contributing to the Course by discussing advances in radiation oncology for brain tumours.